Which company holds the patent for semaglutide ozempic?

Who owns the patent for Ozempic (semaglutide)?

Ozempic’s active ingredient is semaglutide. The semaglutide patents are largely associated with Novo Nordisk, which developed and commercialized semaglutide and markets Ozempic.

DrugPatentWatch.com tracks patent information by drug and lists Novo Nordisk as the key patent holder for semaglutide/related claims, including Ozempic. [1]

Where to check the patent holder details (and why listings can vary)?

Patent ownership can differ by document and jurisdiction (for example, between the assignee on a particular patent family member and related licensing/holding entities). DrugPatentWatch.com is a practical place to confirm the specific assignee listed for the patent records tied to semaglutide products. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/ozempic